Browsing by Author "Maria, Grazia Bongiorni (56603834100)"
Now showing 1 - 1 of 1
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication How are arrhythmias managed in the paediatric population in Europe? Results of the European Heart Rhythm survey(2014) ;Hernández-Madrid, Antonio (57208118344) ;Hocini, Mélèze (7005495090) ;Chen, Jian (15769086600) ;Potpara, Tatjana (57216792589) ;Pison, Laurent (26642819800) ;Blomström-Lundqvist, Carina (55941853900) ;Maria, Grazia Bongiorni (56603834100) ;Nikolaos, Dagres (56604284800) ;Heidi, Estner (56604305700) ;Torben, Bjerregaard Larsen (56604227800) ;Alessandro, Proclemer (53981054200) ;Elena, Sciraffia (56603870600)Irene, Savelieva (56604103000)The aim of this survey was to provide insight into current practice regarding the management of paediatric arrhythmias in Europe. The survey was based on a questionnaire sent via the Internet to the European Heart Rhythm Association (EHRA) electrophysiology research network centres. The following topics were explored: patient and treatment selection, techniques and equipment, treatment outcomes and complications. The vast majority of paediatric arrhythmias concerns children older than 1 year and patients with grown-up congenital heart disease. In 65% of the hospitals there is a specialized paediatric centre, and the most commonly observed arrhythmias include Wolff-Parkinson-White syndrome and atrioventricular nodal re-entry tachycardias (90.24%). The medical staff performing paediatric catheter ablations in Europe are mainly adult electrophysiology teams (82.05% of the centres). Radiofrequency is the preferred energy source used for paediatric arrhythmia ablation. Catheter ablation is only chosen if two or more antiarrhythmic drugs have failed (94.59% of the centres). The majority of the centres use flecainide (37.8%) or atenolol (32.4%) as their first choice drug for prevention of recurrent supraventricular arrhythmias. While none of the centres performed catheter ablation in asymptomatic infants with pre-excitation, 29.7% recommend ablation in asymptomatic children and adolescents. The preferred choice for pacemaker leads in infants less than 1 year old is implantation of epicardial leads in 97.3% of the centres, which continues to be the routine even in patients between 1 and 5 years of age as reported by 75.68% of the hospitals. Almost all centres (94.59%) report equally small number of complications of catheter ablation in children (aged 1-14 years) as observed in adults. © Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2014.